Alteri Investors in its acquisition of CBR Fashion Group from Swedish financial investor EQT.
Advises private equity firms and their portfolio companies on Foreign Corrupt Practices Act and adjacent international risk issues in hundreds of cross-border transactions.
Leads international internal investigations into anti-corruption, kickbacks, violations of sanctions, money laundering, internal controls deficiencies, and other related misconduct for private equity firms and their portfolio companies.
Designs and implements compliance policies, procedures, and systems of internal controls related to a range of international risk matters.
Represented a hospital network in multi-jurisdictional shareholder litigation arising out of an equity restructuring.
Advised a private equity firm in connection with several ongoing actions and investigations arising out of the False Claims Act and state law analogs.
Represented a healthcare provider in a dispute over a multi-year sponsorship agreement.
Represented a private equity firm in post-closing litigation arising out of a price dispute in an infrastructure transaction.
Represented a major national healthcare provider in a qui tam action related to insurance reimbursements.
Represented global private equity firms in an SEC investigation into interactions with sovereign wealth funds.
Counseled a medical device manufacturer in connection with an FDA regulatory action.
Advised a major revenue cycle management company in connection with a federal regulatory action.
Represented a major retail company in connection with a false claims action.
Advised a private equity fund in connection with an SEC investigation into its valuation process.
Counseled a healthcare company vice president in an SEC insider trading investigation.
Represented fund trustees in an SEC investigation into a potential violation of the ‘40 Act.
Represented a Malian woman in a defensive asylum proceeding before the U.S. Immigration Court.
